- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hansen showcases new catheter
Hansen Medical is showcasing its new Lynx Robotic Ablation Catheter this week at Venice Arrhythmias 2009, an International Workshop on Cardiac Arrhythmias in Venice, Italy.
Hansen showcases new catheter
Hansen Medical is showcasing its new Lynx Robotic Ablation Catheter this week at Venice Arrhythmias 2009, an International Workshop on Cardiac Arrhythmias in Venice, Italy. Pending CE Mark approval, the Lynx catheter is expected to be available in the European Union within the first half of 2010.The small, flexible irrigated ablation catheter is designed for use during the treatment of electrophysiology disorders including atrial fibrillation. The company is also showing its Sensei X Robotic Catheter System and the Artisan Extend Control Catheter, both of which were formally introduced Sept. 15. The new Lynx robotic ablation catheter, which is supported by the Sensei X platform, leverages the navigation capability of the Artisan Extend catheter, but in a smaller and more flexible profile. Offering a seven French irrigated ablation tip with a standard sized sheath, the new Lynx catheter has six degrees of freedom. This flexibility facilitates placement in difficult to reach anatomic locations.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
